Research Paper Volume 15, Issue 11 pp 5096—5124
Pan-cancer analysis of Homeobox B9 as a predictor for prognosis and immunotherapy in human tumors
Figure 2. HOXB9 expression in the human pan-cancer. (A) The expression levels of HOXB9 in 31 diverse normal human tissues from the GTEx datasets. (B) The expression levels of HOXB9 in 21 diverse cancer cell lines from the CCLE database. (C) HOXB9 expression in cancers and normal tissues from TCGA database. (D) The expression levels of HOXB9 between tumor and normal tissues in each cancer are based on the integrated data from TCGA and GTEx datasets. (E) Based on the TCGA data, the expression levels of the HOXB9 gene were analyzed by the main pathological stages of CESC, HNSC, PAAD, and LIHC. (F) The immunofluorescence images of HOXB9 protein, nucleus, endoplasmic reticulum (ER), microtubules, and the merged images in HEK293, Hela, and U-2 OS cell lines. *P < 0.05, **P < 0.01, ***P < 0.001.